3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
2
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
12
Neoplasms
6
Stomach Neoplasms
3
Pain, Postoperative
2
Pain
2
Motor Activity
2
Lung Neoplasms
2
Head and Neck Neoplasms
2
Fatigue
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Psychological Well-Being
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Ovarian Neoplasms
1
Lymphoma
1
Lymphedema
1
Lymphatic Metastasis
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Intellectual Disability
1
Incisional Hernia
1
Hot Flashes
1
Hernia, Abdominal
1
Heart Failure
1
Health Behavior
1
Esophageal Neoplasms
1
Interventions
Cytarabine
55
Decitabine
33
Azacitidine
30
Idarubicin
22
venetoclax
21
fludarabine
16
Cyclophosphamide
16
Granulocyte Colony-Stimulating Factor
15
Daunorubicin
12
Mitoxantrone
9
Etoposide
8
Cladribine
8
Busulfan
8
Aclarubicin
8
Homoharringtonine
7
Filgrastim
7
Peripheral Blood Stem Cell Transplantation
6
fludarabine phosphate
5
aclacinomycins
4
Tretinoin
4
Sorafenib
4
Radiotherapy
4
Polymerase Chain Reaction
4
Mycophenolic Acid
4
Lenalidomide
4
Gemtuzumab
4
Cyclosporine
4
Clofarabine
4
Arsenic Trioxide
4
sargramostim
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Leukemia, Myeloid, Acute
×
Control Groups
×
Clear all
NCT04240600
2020-09-03
HEMVEF
Hospital General de Mexico
Phase NA
Unknown
74 enrolled